| Journal Rank | 7817 |
|---|---|
| Impact Score | 3.72 |
| H-Index | 66 |
| SJR | 0.65 |
Cancer biotherapy and radiopharmaceuticals is a reputed research journal publish the research in the field/area related to Medicine (miscellaneous) (Q2); Pharmacology (Q2); Radiology, Nuclear Medicine and Imaging (Q2); Cancer Research (Q3); Oncology (Q3). It is published by Mary Ann Liebert Inc.. The journal has an h-index of 66. The overall rank of this journal is 7817. The more details like ISSN, Journal Quartile, SJR Score, ISSN, and other important details are provided in the following section.
| Journal Title | Cancer Biotherapy and Radiopharmaceuticals |
|---|---|
| Publisher | Mary Ann Liebert Inc. |
| ISSN | 10849785, 15578852 |
| SJR | 0.65 |
| H-Index | 66 |
| Country | United States |
| Quartile | Q2 |
| Online Submission | Submit |
The latest impact score of Cancer biotherapy and radiopharmaceuticals is 3.72.
Credit & Source: Scopus.